Lynx1 Capital Management LP, 10% Owner at TScan Therapeutics, Inc. (TCRX), sold 15,400 shares at $2.51 ($39K) on 2023-05-31, disclosed to the SEC on 2023-06-02.
Open-market sale of $39k TCRX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.51 | 400 | $1K | 2.6% |
| 2 | $2.52 | 15,000 | $38K | 97.4% |
| Total | $2.52 avg | 15,400 | $39K | 100% |
| Filing → |
| KRRO | BUY | 2026-04-02 | $6K | — | Filing → |
| TCRX | BUY | 2025-12-23 | $218K | — | Filing → |
| NEUP | BUY | 2025-10-23 | $6.6M | — | Filing → |